Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose-finding trial of a combined regimen with bevacizumab, immunotherapy, and chemotherapy in patients with metastatic renal cell cancer: An Italian Oncology Group for Clinical Research (GOIRC) study.
Buti S, Lazzarelli S, Chiesa MD, Simonelli C, Re GL, Lheshi A, Simon S, Mattioli R, Caminiti C, Mazza G, Donini M, Passalacqua R; GOIRC (Italian Oncology Group for Clinical Research). Buti S, et al. Among authors: donini m. J Immunother. 2010 Sep;33(7):735-41. doi: 10.1097/CJI.0b013e3181eb8289. J Immunother. 2010. PMID: 20664353 Clinical Trial.
When a thymic carcinoma "becomes" a GIST.
Rossi V, Donini M, Sergio P, Passalacqua R, Rossi G, Buti S. Rossi V, et al. Among authors: donini m. Lung Cancer. 2013 Apr;80(1):106-8. doi: 10.1016/j.lungcan.2013.01.003. Epub 2013 Feb 1. Lung Cancer. 2013. PMID: 23375402
Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg).
Donini M, Buti S, Lazzarelli S, Bozzetti R, Rivoltini L, Camisaschi C, Castelli C, Bearz A, Simonelli C, Lo Re G, Mattioli R, Caminiti C, Passalacqua R; GOIRC (Italian Oncology Group for Clinical Research). Donini M, et al. Target Oncol. 2015 Jun;10(2):277-86. doi: 10.1007/s11523-014-0337-6. Epub 2014 Sep 19. Target Oncol. 2015. PMID: 25230695 Clinical Trial.
Systemic adjuvant therapies in renal cell carcinoma.
Buti S, Bersanelli M, Donini M, Ardizzoni A. Buti S, et al. Among authors: donini m. Oncol Rev. 2012 Oct 8;6(2):e18. doi: 10.4081/oncol.2012.e18. eCollection 2012 Oct 2. Oncol Rev. 2012. PMID: 25992216 Free PMC article. Review.
Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer.
Veccia A, Caffo O, De Giorgi U, Di Lorenzo G, Ortega C, Scognamiglio F, Aieta M, Facchini G, Mansueto G, Mattioli R, Procopio G, Zagonel V, D'Angelo A, Spizzo G, Bortolus R, Donini M, Lo Re G, Massari F, Vicario G, Zucali PA, Alesini D, Bonetti A, Mucciarini C, Nicodemo M, Berruti A, Fratino L, Lodde M, Messina C, Perin A, Santini D, Sava T, Tucci M, Basso U, Maines F, Burgio LS, Galligioni E. Veccia A, et al. Among authors: donini m. Future Oncol. 2016 Feb;12(4):493-502. doi: 10.2217/fon.15.302. Epub 2016 Jan 18. Future Oncol. 2016. PMID: 26776493
Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01-2014).
Passalacqua R, Lazzarelli S, Donini M, Montironi R, Tambaro R, De Giorgi U, Pignata S, Palumbo R, Ceresoli GL, Del Conte G, Tonini G, Morelli F, Nolè F, Panni S, Rondini E, Guida A, Zucali PA, Doni L, Iezzi E, Caminiti C. Passalacqua R, et al. Among authors: donini m. BMC Cancer. 2017 Jul 19;17(1):493. doi: 10.1186/s12885-017-3466-3. BMC Cancer. 2017. PMID: 28724419 Free PMC article.
144 results